MedPath

Etranacogene Dezaparvovec-drlb

Generic Name
Etranacogene Dezaparvovec-drlb

Overview

No overview information available.

Background

No background information available.

Indication

用于治疗患有B型血友病(先天性凝血因子IX缺乏症)的成人。该患者:目前正使用因子IX预防治疗,或目前或以往有危及生命的出血,或反复出现严重的自发性出血。 B型血友病是一种危及生命的遗传性出血罕见病,由单基因缺陷引起,导致肝细胞无法生成凝血因子IX。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor

No clinical trials found

No clinical trials found for this drug

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath